These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9484662

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
    Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K, Kołodziejczyk Z.
    Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
    [Abstract] [Full Text] [Related]

  • 25. [Establishment of enzyme-linked immunosorbent assay (ELISA) for measuring human urinary uromodulin and application of the method in patients with IgA nephropathy].
    Liu Y, Chen YQ, Zhou JJ, Han J, Liang Y, Li XY, Zhang H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr 18; 44(2):307-10. PubMed ID: 22517010
    [Abstract] [Full Text] [Related]

  • 26. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC.
    Arthritis Rheum; 2004 Sep 18; 50(9):2882-90. PubMed ID: 15457456
    [Abstract] [Full Text] [Related]

  • 27. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul 18; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun 18; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 31. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Jun 18; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 32. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
    Wagrowska-Danilewicz M, Danilewicz M, Stasikowska O.
    Pol J Pathol; 2005 Jun 18; 56(3):121-6. PubMed ID: 16334979
    [Abstract] [Full Text] [Related]

  • 33. Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy.
    Mori H, Kaneko Y, Narita I, Goto S, Saito N, Kondo D, Sato F, Ajiro J, Saga D, Ogawa A, Sakatsume M, Ueno M, Tabei K, Gejyo F.
    Clin Exp Nephrol; 2005 Dec 18; 9(4):297-303. PubMed ID: 16362156
    [Abstract] [Full Text] [Related]

  • 34. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct 18; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 35. [The role of monocyte chemotactic and activating factor (MCAF)/monocyte chemoattractant protein (MCP)-1 in subgroups of rapidly progressive glomerulonephritis].
    Sakai N, Wada T, Furuichi K, Takaeda C, Shimizu M, Iwata Y, Yoshimoto K, Shimizu K, Kobayashi K, Takeda S, Kida H, Mukaida N, Matsushima K, Yokoyama H.
    Nihon Jinzo Gakkai Shi; 1999 Oct 18; 41(7):704-11. PubMed ID: 10572396
    [Abstract] [Full Text] [Related]

  • 36. Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis.
    Besbas N, Ozaltin F, Catal F, Ozen S, Topaloglu R, Bakkaloglu A.
    Pediatr Nephrol; 2004 Aug 18; 19(8):864-8. PubMed ID: 15206029
    [Abstract] [Full Text] [Related]

  • 37. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
    Zheng D, Wolfe M, Cowley BD, Wallace DP, Yamaguchi T, Grantham JJ.
    J Am Soc Nephrol; 2003 Oct 18; 14(10):2588-95. PubMed ID: 14514736
    [Abstract] [Full Text] [Related]

  • 38. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.
    Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A.
    Lab Invest; 1995 Dec 18; 73(6):804-9. PubMed ID: 8558841
    [Abstract] [Full Text] [Related]

  • 39. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    J Diabetes Complications; 2003 Dec 18; 17(1):11-5. PubMed ID: 12505750
    [Abstract] [Full Text] [Related]

  • 40. Urinary monocyte chemoattractant protein-1 in renal disease.
    Kim MJ, Tam FW.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2022-30. PubMed ID: 21851811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.